Aeglea BioTherapeutics (AGLE) Q4 2022 Earnings

2MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.37
-0.31
-0.24
-0.18

Details

Expected EPS
-0.2
Actual EPS
-0.18
Surprise EPS
0.02
Surprise Percent
+10%

Description

Aeglea BioTherapeutics (AGLE) has reported earnings of -0.18 per share for Q4 2022.

0 Comments

Share your thoughts